Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel - Wikidata - awgldk - TriplyDB

Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel

Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel

http://www.wikidata.org/entity/Q21261394

about

Understanding the gastrointestinal manifestations of Fabry disease: promoting prompt diagnosis Pain management strategies for neuropathic pain in Fabry disease--a systematic review Paediatric Fabry disease Small-fibre neuropathies--advances in diagnosis, pathophysiology and management.Impaired small fiber conduction in patients with Fabry disease: a neurophysiological case-control study Cerebral hemodynamics and endothelial function in patients with Fabry disease No Fabry Disease in Patients Presenting with Isolated Small Fiber Neuropathy Self-administered version of the Fabry-associated pain questionnaire for adult patients.Increased expression of Trpv1 in peripheral terminals mediates thermal nociception in Fabry disease mouse model.Pain in Fabry Disease: Practical Recommendations for Diagnosis and Treatment.Autophagy-lysosome pathway associated neuropathology and axonal degeneration in the brains of alpha-galactosidase A-deficient mice.Electroneuromyographic Features in Fabry Disease: A Retrospective Review.Chronic intestinal pseudo-obstruction. Did you search for lysosomal storage diseases?Fabry disease: a rare cause of neuropathic pain.Fabry disease in infancy and early childhood: a systematic literature review.The Psychosocial Impact of Fabry Disease on Pediatric Patients.Changes in Ionic Conductance Signature of Nociceptive Neurons Underlying Fabry Disease Phenotype.When arthralgia is not arthritis Diagnostic dilemma and delay in Fabry disease: insights from a case series of young female patients.Pain: a prevalent feature in patients with mucopolysaccharidosis. Results of a cross-sectional national survey.Neuropathic pain in a Fabry disease rat model.Significant improvement in Fabry disease podocytopathy after 3 years of treatment with agalsidase beta.

P2860

Q26745698-70A4F2EC-F3C2-40F0-B688-28AA71877ECD Q26766561-5A48FDC7-D4A8-47C9-A2A5-27A368F6012F Q26770283-C79F551F-3BEB-4E7B-954F-419925112E02 Q34277762-2DBB915F-A0D2-49A2-8FB8-32DF423AE336 Q34739186-5D929B3C-E322-4848-B263-2EB0056E0465 Q35037435-F8DBD19A-163A-41E6-8701-712C20792234 Q35920645-6E73D036-5340-4F8C-9D95-D5D8E7977EBB Q36069971-D884DAE2-AC75-4B9E-80FD-EF310F730CD2 Q37229008-0315DA85-0B66-459C-8740-4E0346306A7E Q37352268-AAAD4B5A-C74D-483B-89C1-24E6744FF0EF Q37600470-B2E99E96-5E1D-4343-89F9-463DEBC0EF36 Q37703799-20AF89CF-28D5-4DC7-A980-13AFA1B6B4EA Q37725235-5DFA214B-0E93-4916-8ED6-E550D6DF79C9 Q38133441-96E325E2-FA03-4EBD-A281-F3EC857B5017 Q38252008-4029FCDB-F181-4E68-8243-04FCF422D93A Q39401966-E92CFDF3-A847-4183-8A6B-FE9F97783D58 Q41013852-2737ECFA-CABC-4349-9F80-41286C727FFC Q41884483-F4279DF3-B2B0-4B41-A570-80E819817320 Q47818876-A24EC317-EC30-4EC2-A5DA-2178B6AB5104 Q48070205-6BFA7A50-850D-4B7C-B9DD-EB221DF95F98 Q52347263-9C210FB3-4DF7-4CC7-BB65-9C4CF3FA1277 Q52872249-7BFA608B-8C10-4D7B-B4C0-B08EFF394661

P2860

Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel

http://www.wikidata.org/entity/Q21261394

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Early diagnosis of peripheral ...... the report of an expert panel

@ast

Early diagnosis of peripheral ...... the report of an expert panel

@en

Early diagnosis of peripheral ...... the report of an expert panel

@en-gb

Early diagnosis of peripheral ...... the report of an expert panel

@nl

type

label

Early diagnosis of peripheral ...... the report of an expert panel

@ast

Early diagnosis of peripheral ...... the report of an expert panel

@en

Early diagnosis of peripheral ...... the report of an expert panel

@en-gb

Early diagnosis of peripheral ...... the report of an expert panel

@nl

prefLabel

Early diagnosis of peripheral ...... the report of an expert panel

@ast

Early diagnosis of peripheral ...... the report of an expert panel

@en

Early diagnosis of peripheral ...... the report of an expert panel

@en-gb

Early diagnosis of peripheral ...... the report of an expert panel

@nl

P1433

Q21261394-214C58FC-8822-4147-84FD-09A1F0026050

P1476

Q21261394-6C8A9EF6-E5BF-4A90-8089-86ACC14DF273

P2093

Q21261394-200CF4FC-8AA0-40C3-B53A-370E40B02AA2

Q21261394-7C68B8AD-51C7-4BBF-9F1A-0B4B44F10965

Q21261394-89F4DCE0-E273-4762-A163-E80B623DC902

Q21261394-92F34D2B-FB8F-46AE-9B9E-BCE0583C8794

Q21261394-A658E539-230E-43B7-887B-CFF09D17BAA1

Q21261394-DFB58DB7-0CC9-4780-9CD8-3A550664449E

Q21261394-ECFA9C63-0B2D-4D93-A2B0-BC3BAB49C8E9

Q21261394-F0817780-D3CB-467F-A19D-AF3D5E97303E

P275

Q21261394-0311298A-69A7-4CB3-8ADC-26611D12F405

P2860

Q21261394-00DCD733-2D53-4649-9D90-68A6E4512327

Q21261394-051C8709-F6D6-478E-949E-3BB3E2781615

Q21261394-05347558-3D93-4338-A658-186FC4571102

Q21261394-078B8540-0B42-46CD-A363-75D10A8591E0

Q21261394-0A6DA341-223D-4B8F-A067-80D0FB7C7612

Q21261394-0BAB26C9-6E0B-407A-97B7-7570549827A5

Q21261394-0DFA79EC-99AC-4305-8382-2AE33CDEFDAD

Q21261394-18FDE616-0A1E-45AE-83A6-9871B5B53D5A

Q21261394-19A20D92-ECA7-43C8-9878-0E6130C32E59

Q21261394-1C586400-5A7C-4EE3-A02E-4064F4571FED

P2888

Q21261394-67585ACD-573B-49AA-8680-03BE6D2F6EEE

P304

Q21261394-92A553AE-F919-4D8E-8313-30EC03B0D5C9

P31

Q21261394-91F3C1BD-2C7D-4C33-9FA7-8B8383969492

Q21261394-E12571E2-8E32-4D91-9D11-38B086964737

P3181

Q21261394-B544186D-FF04-4060-9949-D5AA0AA1FE49

P356

Q21261394-0C3FC791-8316-4298-A9CD-E7D8063011DD

P407

Q21261394-EBAE9862-20F0-4F9A-9D51-55C53A1B1B0C

P433

Q21261394-8DA950DC-4248-464B-8E10-0E9CB29041F1

P478

Q21261394-7D46620C-0322-4B2B-B6C3-5CF9D959AEB0

P5008

Q21261394-D83A3D9C-46F0-410A-BAD2-616AF21D0857

P577

Q21261394-F414EEDC-ECA3-47FB-9881-1F57380B7660

P5875

Q21261394-CD8737A3-D21D-474D-A4BA-86CFBE61D85B

P6179

Q21261394-8D1E58BF-825A-4921-8167-A0D2CB69CAF1

P698

Q21261394-5A653A77-D12F-48F9-B224-0302EEE236B0

P921

Q21261394-14E9DF27-806E-4494-AA85-CCEAD190E24D

Q21261394-760408CE-602E-4998-B3F2-1556E5E394ED

Q21261394-7baae6b1-1478-4c8d-93f3-bf59f311453e

Q21261394-F20450E0-A657-4B57-8E96-EEB2AE2804E5

P932

Q21261394-ACB9B53C-28CB-4976-B071-0C9B6E8190C7

P3181

P356

1471-2377-11-61

P1433

P1476

Early diagnosis of peripheral ...... the report of an expert panel

@en

P2093

Alessandro P Burlina

http://www.w3.org/2001/XMLSchema#string

Anette Torvin Møller

http://www.w3.org/2001/XMLSchema#string

Claudia Sommer

http://www.w3.org/2001/XMLSchema#string

Gary J Bennett

http://www.w3.org/2001/XMLSchema#string

Juan M Politei

http://www.w3.org/2001/XMLSchema#string

Katherine B Sims

http://www.w3.org/2001/XMLSchema#string

Max J Hilz

http://www.w3.org/2001/XMLSchema#string

Ralf Baron

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2 mg/kg

Long-term safety and efficacy of enzyme replacement therapy for Fabry disease

Recommendations for the pharmacological management of neuropathic pain: an overview and literature update

Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of twenty-two hemizygous male patients.

Small-fiber neuropathy

Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology

Enhanced endothelium-dependent vasodilation in Fabry disease

A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies

Mechanisms of Disease: neuropathic pain—a clinical perspective

Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease

P2888

1471-2377-11-61

P304

61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4068469

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1471-2377-11-61

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2011-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51171904

http://www.w3.org/2001/XMLSchema#string

P6179

1009204473

http://www.w3.org/2001/XMLSchema#string

P698

21619592

http://www.w3.org/2001/XMLSchema#string

P921

neuropathic pain

P932

3126707

http://www.w3.org/2001/XMLSchema#string